Randomised Trial on Allogeneic Haematopoietic Stem Cell Transplantation in Patients Under the Age of 60 Years With Acute Myeloid Leukemia of Intermediate Risk in First Complete Remission and a Matched Sibling or Unrelated Donor (ETAL-1).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cytarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms ETAL-1
Most Recent Events
- 03 Dec 2014 Biomarkers information updated
- 06 Oct 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2010-019377-15).
- 03 Dec 2010 New trial record